On Feb 14, 2022 Locus Biosciences closed a Venture – Series Unknown round and raised $10,500,000 from investors, featuring lead investors . About the company: […]
Series A – Indapta Therapeutics
On Feb 10, 2022 Indapta Therapeutics closed a Series A round and raised $50,000,000 from Leaps by Bayer, Lonza, Myeloma Investment Fund, RA Capital Management, […]
Post-IPO Debt – Innate Pharma
On Jan 5, 2022 Innate Pharma closed a Post-IPO Debt round and raised €28,700,000 from BNP Paribas, Societe Generale, featuring lead investors . About the […]
Series B – Tavotek Biotherapeutics
On Nov 18, 2021 Tavotek Biotherapeutics closed a Series B round and raised $35,000,000 from CS Capital, Fontus Capital, featuring lead investors CS Capital. About […]
Series B – Arbor Biotechnologies
On Nov 9, 2021 Arbor Biotechnologies closed a Series B round and raised $215,000,000 from Ally Bridge Group, ARCH Venture Partners, ArrowMark Partners, Deep Track […]
Post-IPO Equity – Autolus
On Nov 8, 2021 Autolus closed a Post-IPO Equity round and raised $250,000,000 from Blackstone Group, featuring lead investors Blackstone Group. About the company: Autolus […]
Series B – Antios Therapeutics
On Nov 3, 2021 Antios Therapeutics closed a Series B round and raised $75,000,000 from Adage Capital Management, Aisling Capital, Altium Capital, Amzak Health Investors, […]
Grant – InterveXion Therapeutics
On Nov 1, 2021 InterveXion Therapeutics closed a Grant round and raised $13,800,000 from National Institutes of Health, featuring lead investors National Institutes of Health. […]
Grant – InterveXion Therapeutics
On Nov 1, 2021 InterveXion Therapeutics closed a Grant round and raised $13,800,000 from National Institutes of Health, featuring lead investors National Institutes of Health. […]
Series C – Cambrian Biopharma
On Oct 26, 2021 Cambrian Biopharma closed a Series C round and raised $100,000,000 from Anthos Capital, Apeiron Investment Group, Future Ventures, Moore Capital, SALT […]
